debrisoquin has been researched along with Crohn Disease in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ladero, JM | 1 |
| Benítez, J | 1 |
| Serrano, M | 1 |
| García-Paredes, J | 1 |
| Diaz-Rubio, M | 1 |
1 other study available for debrisoquin and Crohn Disease
| Article | Year |
|---|---|
Debrisoquine oxidation polymorphism in patients with chronic inflammatory bowel disease.
Topics: Adult; Colitis, Ulcerative; Crohn Disease; Debrisoquin; Female; Humans; Male; Oxidation-Reduction; P | 1995 |